318 filings
Page 10 of 16
8-K
kz1sn2sd 9m
16 Jul 13
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
12:00am
8-K
yv09w2wb0f251
24 Jun 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
mqxk9wumu
13 Jun 13
Anthera Pharmaceuticals Announces Personnel Changes
12:00am
S-8
58yzk
17 May 13
Registration of securities for employees
12:00am
8-K
bb302z9ar 26jmz
17 May 13
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
12:00am
EFFECT
kuqo4yoovh0plcxhf 9t
18 Apr 13
Notice of effectiveness
12:00am
424B5
5wqpyivoc2wu qnc6fy
5 Apr 13
Prospectus supplement for primary offering
12:00am
8-K
bfxhjfxnrq1pb hq
5 Apr 13
Entry into a Material Definitive Agreement
12:00am
S-3MEF
aleadzk9l qb998g
5 Apr 13
Registration of additional securities for an S-3
12:00am
DEFA14A
s3cg8k tz
5 Apr 13
Additional proxy soliciting materials
12:00am
8-K
fba8svd qx9e82zf
28 Mar 13
Other Events
12:00am
8-K
rmo9482mlj jc8
26 Mar 13
Anthera Pharmaceuticals Reports 2012 Fourth Quarter and Fiscal Year Financial Results
12:00am
8-K
hcjfuvadc7iyi4ucb9
25 Feb 13
Other Events
12:00am
8-K
cebhxvo
5 Feb 13
Departure of Directors or Certain Officers
12:00am
424B5
nb3vy6fhl2cyt8b1k19
28 Jan 13
Prospectus supplement for primary offering
12:00am